PharmaVoice

JULY 15, 2022

The incoming CEO aims to build on the buzz around the company’s leading-edge gene therapy tech.

246

246

Pharmaceutical Technology

JULY 15, 2022

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. In a budget change proposed in February and confirmed in May , California’s Department of Health Care Access and Information (HCAI) requested a one-time investment of $100 million for Newsom’s CalRx Biosimilar Insulin initiative.

Insurance 131

Insurance Documentation Packaging 131

pharmaphorum

JULY 15, 2022

Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the efficacy of its AKL-T01 in patients with the autoimmune disorder systemic lupus erythematosus (SLE). The PureTech group company – which scored the first FDA and EMA approvals for a DTx for attention-deficit hyperactivity disorder (ADHD) – is developing AKL-T01 to tackle cognitive impairments that can affect people with SLE.

FDA 129

FDA 129

Pharmacy Times

JULY 15, 2022

The FDA approved tirzepatide for the treatment of type 2 diabetes on May 13, 2022.

FDA 123

FDA 123

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

JULY 15, 2022

Pfizer’s tyrosine kinase inhibitor Xalkori has picked up a fourth approval from the FDA, adding a new use in the treatment of a rare form of benign tumour that typically affects children and young adults. Xalkori (crizotinib) has been cleared for inflammatory myofibroblastic tumours (IMT), which appear in organs like the lung, stomach, bladder or liver.

FDA 116

FDA Chemotherapy Labelling 116

Pharmacy Times

JULY 15, 2022

Triptans are contraindicated in patients with ischemic heart disease, cerebrovascular disease, uncontrolled hypertension, and peripheral artery disease.

123

123

Pharmacy Times

JULY 15, 2022

Ryan Burke, PharmD, director of professional affairs at Pharmacy Technician Certification Board, discusses more advanced roles for pharmacy technicians and how they can continue to grow beyond their current roles.

123

123

Pharmaceutical Technology

JULY 15, 2022

Health Canada has granted approval for the usage of Moderna’s messenger RNA (mRNA) Covid-19 vaccine, Spikevax, in a 25µg two-dose regimen for active immunisation to prevent Covid-19 in children aged six months to five years. So far, children aged below five years were not eligible to receive the Covid-19 vaccine in Canada. The two-dose initial vaccine regimen in children of this age group is completed in one month, which is the same dosing schedule in adults, adolescents and children aged above

Vaccines 105

Vaccines 105

Pharmacy Times

JULY 15, 2022

Debbie Weitzman of Cardinal Health, discussed how independent retail pharmacies quickly adjusted during the pandemic.

Independent Pharmacies 123

Independent Pharmacies 123

European Pharmaceutical Review

JULY 15, 2022

The pharmaceutical sector is not typically seen as a highly polluting, ‘heavy industry’ but it is far from green. In its 2021 report Delivering a ‘Net Zero’ National Health Service , the UK’s NHS attributes as much as a quarter of its carbon footprint to medicines. A deep carbon footprint is a common hallmark of energy intensive manufacturing processes – and the manufacture of pharmaceuticals is no exception.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmExec

JULY 15, 2022

Podcast recognized for its excellence in apps and podcasts category.

98

98

pharmaphorum

JULY 15, 2022

Health technology assessment (HTA) agency NICE has finalised its guidance on Amarin’s Vazkepa, clearing the path for GPs to start prescribing the drug in up to 425,000 NHS patients at high cardiovascular risk because of raised triglyceride levels. The just-published final technology appraisal document recommends that Vazkepa (icosapent ethyl) can be prescribed to people in England and Wales for adult patients with high-risk cardiovascular disease and elevated levels of triglycerides (1.7 m

Documentation 98

Documentation 98

European Pharmaceutical Review

JULY 15, 2022

A report assessing the current climate for antimicrobial innovation in Brazil, India, and South Africa, reveals that removing regulatory hurdles to accelerate the approval of new antibiotics will help to improve their development and access. Antimicrobial resistance (AMR) is a growing challenge to the healthcare sector, as antibiotics are a linchpin of modern medicine.

98

98

Pharmacy Times

JULY 15, 2022

Pharmacists can recommend calcium, smoking cessation products, and vitamin D to stave off this common condition.

73

73

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmExec

JULY 15, 2022

Industry leaders discuss new technologies, research, and investment strategies.

72

72

Pharmacy Times

JULY 15, 2022

Desitin is used to provide relief of skin irritation caused by a diaper rash.

65

65

Pharmaceutical Technology

JULY 15, 2022

The Brazilian Health Regulatory Agency (Anvisa) has granted emergency use authorization for Sinovac Biotech’s Covid-19 vaccine, CoronaVac, in children aged three to five years. Subjects in this age group can receive the same vaccine dosage authorised in patients aged six to 17 years, as well as adults. Furthermore, there exists no restriction on vaccine usage in immunosuppressed children aged three to five years.

Vaccines 64

Vaccines Dosage Immunization 64

Pharmacy Times

JULY 15, 2022

Oritavancin (Orbactiv) is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms.

65

65

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

JULY 15, 2022

Data from APHINITY study shows Roche’s Perjeta-based regimen reduces the risk of disease returning for people with HER2-positive early breast cancer

56

56

Pharmacy Times

JULY 15, 2022

Pursuing the expanded access process for treatment may be the best option for patients who have exhausted all available FDA-approved drugs and clinical trials.

FDA 65

FDA 65

Pharmaceutical Commerce

JULY 15, 2022

Partnership allows for distribution of packager’s temperature-controlled container.

52

52

Pharmacy Times

JULY 15, 2022

Provepharm filed its application with the agency in September 2021, and, with the new approval, its US affiliate will market the product directly in the United States.

FDA 65

FDA 65

PharmExec

JULY 15, 2022

Patients with Crohn's disease and ulcerative colitis face a high disease burden.

52

52

Pharmacy Times

JULY 15, 2022

Investigators argue that much of the language around women who give birth later in life is rooted in ableism and ageism and is out of step with current childbirth trends.

65

65

Outsourcing Pharma

JULY 15, 2022

Clinical Trial Navigator, from AmerisourceBergen, is designed to help sponsors pair with oncology practices to boost patient recruitment opportunities.

52

52

Pharmacy Times

JULY 15, 2022

Being able to acknowledge those missteps that may have been made that may have prevented you from delivering as culturally competent care, and being able to recalibrate and to take the correction is an important step.

65

65

pharmaphorum

JULY 15, 2022

SAE Media Group’s 5th Annual. Ophthalmic Drugs Conference. 21 – 22 November 2022 | London, UK. [link]. Delving into advanced R&D and Delivery of Ocular Therapeutics. SAE Media Group’s 5th Annual Ophthalmic Drugs Conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing good clinical trial data.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmacy Times

JULY 15, 2022

Crizotinib has also been approved to treat non-small cell lung cancer that has spread to other parts of the body and is caused by a defect in either the ALK or ROS1 gene.

FDA 65

FDA 65

pharmaphorum

JULY 15, 2022

Teva has asked the Supreme Court to look at a judgment in a $235 million patent dispute with GSK that it claims could undermine the ability of generic drugmakers to bring new products to market, and thereby help reduce drug prices. The case hinges around the concept of “ skinny labelling ” which was introduced to stop drugmakers extending the exclusivity period for their branded medicines – through a stream of new indications or patient populations – that can be protected with so-cal

Labelling 52

Labelling 52

Pharmacy Times

JULY 15, 2022

Pharmacies have a lot of opportunities to think out of the box, to be innovative, and continue to drive that power of community that we're highlighting at the event here.

65

65

Fossil Remedies

JULY 15, 2022

Cardiac and Diabetic. In recent years, diabetes and heart diseases are quite common. They are called lifestyle diseases because the fundamental cause is sedentary life and lack of exercise. As the number of people affected by these problems is increasing, there is a high demand for medicines required to treat them. If you are planning to launch Cardiac Diabetic PCD Pharma Franchise, then it is the best time.

Packaging 52

Packaging 52

pharmaphorum

JULY 15, 2022

Illumina’s attempt to prevent the European Commission from carrying out an antitrust review of its $8 billion takeover last year of cancer diagnosis firm Grail has been defeated in an EU court. The EU General Court has ruled that the Commission can investigate the merger, unswayed by Illumina’s argument that it should have no jurisdiction over the deal because Grail does not currently have a commercial presence within the EU.

52

52

Pharma Times

JULY 15, 2022

Armed forces veterans and people who were exposed to asbestos could benefit from the therapy

48

48